
The BRIGHT Study: Comparing Toujeo® (insulin glargine 300 U/mL) and Insulin Degludec 100 U/mL
Efficacy and safety considerations are essential for effective Type 2 diabetes management.
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.
Adverse event reporting can be found at the bottom of the page.


Efficacy and safety considerations are essential for effective Type 2 diabetes management.

.jpg)


Resources to inform, aid and give insight across therapy areas, to help implement strategies to reduce inequalities in healthcare.
Collaboration with healthcare organisations and the NHS to deliver real value beyond our medicines.


.jpg)

This course is intended for NHS Healthcare professionals only.



MAT-XU-2305062 (v2.0) Date of preparation: November 2025